Amoxapine and imipramine in the treatment of depressed outpatients: a controlled study

Publisher Website
Google Scholar
Abstract
In a double-blind, controlled study, 158 outpatients with unipolar depression were treated for 6 wk with amoxapine, imipramine or placebo to assess the antidepressant effects of the new dibenzooxazepine compound, amoxapine. Forty-five amoxapine, 43 imipramine and 27 placebo patients completed at least 4 wk of treatment. Active drugs produced significantly more improvement at treatment endpoint, according to several physician-rate measures, but patient-rated measures failed to differentiate among treatments. Both active drugs at daily doses up to 200 mg produced an equal amount of moderate and marked global improvement and both produced significantly more side effects than did placebo.

This publication has 0 references indexed in Scilit: